Market Overview The Decitabine Drug Market is experiencing steady growth as epigenetic therapies become increasingly important in the treatment of hematological malignancies. Decitabine is a hypomethylating agent approved for the treatment of myelodysplastic syndromes and acute myeloid leukemia, particularly in patients ineligible for intensive chemotherapy. By reactivating silenced...